Literature DB >> 17136884

Recurrent Campylobacter lari bacteremia in X-linked agammaglobulinemia: a case report and review.

Orathai Jirapongsananuruk1, Kalaya Wanotayan, Wanatpreeya Phongsamart, Kulkanya Chokephaibulkit, Nualanong Visitsunthorn, Voravich Luangwedchakarn, Nirun Vanprapar, Pakit Vichyanond.   

Abstract

X-linked agammaglobulinemia (XLA) is a primary immune deficiency disease with a B-cell defect. We present the first XLA patient who had recurrent Campylobacter lari bacteremia. High dose intravenous immunoglobulin combined with azithromycin once per week, and a complete avoidance of bacterial reservoirs may be helpful for the prevention of C. lari bacteremia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136884

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  4 in total

Review 1.  Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.

Authors:  Stuart E Turvey; Sara H Leo; Annette Boos; Gregory D Deans; Julie Prendiville; Richard I Crawford; Christof Senger; Mary Ellen Conley; Peter Tilley; Anne Junker; Loretta Janz; Robert Azana; Linda Hoang; Tracy L Morton
Journal:  J Clin Immunol       Date:  2012-07-28       Impact factor: 8.317

2.  Recurrent Campylobacter jejuni bacteremia in a patient with hypogammaglobulinemia: A case report.

Authors:  Youie Kim; Ju Ae Shin; Seung Beom Han; Bin Cho; Dae Chul Jeong; Jin Han Kang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Campylobacter jejuni Bacteremia in a Liver Cirrhosis Patient and Review of Literature: A Case Study.

Authors:  Jin Gu Yoon; Saem Na Lee; Hak Jun Hyun; Min Joo Choi; Ji Ho Jeon; Eunju Jung; Seonghui Kang; Jeeyong Kim; Ji Yun Noh; Won Suk Choi; Joon Young Song; Hee Jin Cheong; Woo Joo Kim
Journal:  Infect Chemother       Date:  2017-05-26

4.  IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.

Authors:  Jeroen D Langereis; Stefanie S Henriet; Saskia Kuipers; Corry M R Weemaes; Mirjam van der Burg; Marien I de Jonge; Michiel van der Flier
Journal:  J Clin Immunol       Date:  2018-01-15       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.